Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1619-1625

  Bonassi, Stefano ^a   Hagmar, Lars ^b   Strömberg, Ulf ^b   Huici Montagud, Alicia ^c   Tinnerberg, Håkan ^b   Forni, Alessandra ^d   Heikkilä, Pirjo ^e   Wanders, Saskia ^f   Wilhardt, Peter ^g   Hansteen, Inger Lise ^f   Knudsen, Lisbeth E ^g   Norppa, Hannu ^e  

^a UNIVERSITY OF GENOA   (Italy)

^b LUND UNIVERSITY   (Sweden)

^c Inst Nac Seguritat i Higiene el T   (Spain)

^d UNIVERSITY OF MILAN   (Italy)

^e FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^f TELEMARK HOSPITAL   (Norway)

^g NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

ADULT; AGED; ARTICLE; CANCER; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOGENS; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; COHORT STUDIES; FEMALE; FINLAND; HUMANS; ITALY; LOGISTIC MODELS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS; OCCUPATIONAL EXPOSURE; PREDICTIVE VALUE OF TESTS; RANDOM ALLOCATION; RISK FACTORS; SCANDINAVIA; SMOKING;

EID: 0034653699     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Schatzkin, A., Freedman, L. S., Schiffman, M. H., and Dawsey, S. M. Validation of intermediate end points in cancer research. J. Natl. Cancer Inst., 82: 1746-1752, 1990.
2. McMichael, A., and Hall, J. The use of biological markers as predictive early-outcome measures in epidemiological research. In: P. Toniolo, P. Boffetta, D. E. G. Shuker, N. Rothman, B. Hulka, and N. Pearce (eds.), Application of Biomarkers in Cancer Epidemiology, pp. 281-289. IARC Scientific Publ. No. 142. Lyon, France; IARC, 1997.
3. Tucker, J. D., Eastmond, D. A., and Littlefield, L. G. Cylogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies. In: P. Toniolo, P. Boffetta, D. E. G. Shuker, N. Rothman, B. Hulka, and N. Pearce (eds.), Application of Biomarkers in Cancer Epidemiology, pp. 185-200. IARC Scientific Publ. No. 142. Lyon, France: IARC, 1997.
4. Liou, S-H., Lung, J-C., Chen, Y-H., Yang, T., Hsieh, L-L., Chen, C-J., and Wu, T-N. Increased chromosome-type aberration frequencies as biomarkers of cancer risk in a Blackfoot endemic area. Cancer Res., 59: 1481-1484, 1999.
5. Boveri, T. Zur Frage der Entstehung Maligner Tumoren, pp. 1-64. Jena, Germany: Gustav Fisher, 1914.
6. Hagmar, L., Brøgger, A., Hansteen, I-L., Heim, S., Högstedt, B., Knudsen, L., Lambert, B., Linnainmaa, K., Mitelman, F., Nordenson, I., Reuterwall, C., Salomaa, S., Skerfving, S., and Sorsa, M. Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Res., 54: 2919-2922, 1994.
7. Bonassi, S., Abbondandolo, A., Camurri, L., Dal Pra', L., De Ferrari, M., Degrassi, F., Forni, A., Lamberti, L., Lando, C., Padovani, P., Sbrana, I., Vecchio, D., and Puntoni, R. Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet., 79: 133-135, 1995.
8. Hagmar, L., Bonassi, S., Strömberg, U., Brøgger, A., Knudsen, L., Norppa, H., and Reuterwall, C. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res., 58: 4117-4121, 1998.
9. Hagmar, L., Bonassi, S., Strömberg, U., Micoczy, Z., Lando, C., Hansteen, I-L., Huici Montagud, A., Knudsen, L., Norppa, H., Reuterwall, C., Tinnemberg, H., Brøgger, A., Forni, A., Högsted, B., Lambert, B., Mitelman, F., Nordenson, I., Salomaa, S., and Skerfving, S. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat. Res., 405: 171-178, 1998.
10. International System for Human Cytogenetic Nomenclature. An International System for Human Cytogenetic Nomenclature. Birth Defects, 21: 1-118, 1985.
11. Wacholder, S., Silverman, D. T., McLaughlin, J. K., and Mandel, J. S. Selection of controls in case-control studies. III. Design options. Am. J. Epidemiol., 135: 1042-1050, 1992.
12. Wacholder, S., McLaughlin, J. K., Silverman, D. T., and Mandel, J. S. Selection of controls in case-control studies. I. Principles. Am. J. Epidemiol., 135: 1019-1028, 1992.
13. Nordic Study Group on the Health Risk of Chromosome Damage. A Nordic data base on somatic chromosome damage in humans. Mutat. Res., 241: 325-337, 1991.
14. Hosmer, D. W., and Lemeshow, S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
15. Rothman, K. J. Modern Epidemiology, Boston, Little & Brown, 1986.
16. Bogen, K. T. Reassessment of human peripheral T-lymphocyte lifespan deduced from cytogenetic and cytotoxic effects of radiation. Int. J. Radiat. Biol., 64: 195-204, 1993.
17. Mitelman, F., Mertens, F., and Johansson, B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat. Genet., 15: 417-474, 1997.
18. Ried, T., Liyanage, M., du Manoir, S., Heselmeyer, K., Auer, G., Macville, M., and Schrök, E. Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping. J. Mol. Med., 75: 801-814, 1997.
19. Sorsa, M., Osterman-Golkar, S., Peltonen, K., Saarikoski, S. T., and Šrám, R. Assessment of exposure to butadiene in the process industry. Toxicology, 113: 77-83, 1996.
20. el-Zein, R., Conforti-Froes, N., and Au, W. W. Interactions between genetic predisposition and environmental toxicants for development of lung cancer. Environ. Mol. Mutagen., 30: 196-204, 1997.
21. Norppa, H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ. Health Perspect., 105 (Suppl. 4); 829-835, 1997.
22. Šrám, R. J. Effect of Glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects. Environ. Health Perspect., 106 (Suppl. 1): 231-239, 1998.
23. Knudsen, I., E., Norppa, H., Gamborg, M. O., Nielsen, P. S., Okkels, H., Soll-Johanning, H., Raffn, E., Järventaus, H., and Autrup, H. Chromosomal aberrations induced by urban air pollution in humans: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol. Biomarkers Prev., 8: 303-310, 1999.
24. Tlsty, T. D., Briot, A., Gualberto, A., Hall., I., Hess., S., Hixon, M., Kuppuswamy, D., Romanov, S., Sage, M., and White, A. Genomic instability and cancer. Mutat. Res., 337: 1-7, 1995.
25. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instabilities in human cancers. Nature (Lond.), 396: 643-649, 1998.
26. Blount, B. C., Mack, M. M., Wehr, C. M., MacGregor, J. T., Hiatt, R. A., Wang, G., Wickramasinghe, S. N., Everson, R. B., and Ames, B. N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implication for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA, 94: 3290-3295, 1997.